Multiple Sclerosis (MS)
Facilitating Clinical Trials for Immune-Mediated Disorders
Biorasi understands the importance of innovative project management solutions on variables in disease manifestation across MS
Biorasi Brings a Sharp Focus to MS Clinical Trials
Multiple Sclerosis (MS) can prove to be a challenging therapeutic area for clinical research without the right CRO as your guide. With a heterogenous set of symptoms – ranging from physical to mental presentations, and from isolated attacks to progressive forms – ensuring the efficacy of an MS study relies on smart trial design and a robust project management solutions.
A Comprehensive Strategy for MS Studies
Biorasi leverages data intelligence, innovative project management, and a legacy of neurology expertise to keep your trials on track and maintain control over common variables in MS studies:
- Our TALOS™ Control Center provides 24/7 insight into your clinical trials, from monitoring daily progress to planning future milestones.
- Our program management methodology focuses on optimizing your trials, meeting all MS study challenges – from recruitment to post-market strategy.
- Biorasi’s Neurology Center of Excellence combines decades CNS knowledge, MS clinical trial expertise, and customized strategies to ensure the most optimal study outcome.